Related Experiment Video
Updated: Apr 3, 2026
06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
10.1K
BRAF Mutation in Colorectal Cancer: An Update
1SIB Swiss Institute of Bioinformatics, Bioinformatics Core Facility, Lausanne, Switzerland.
Biomarkers in Cancer
|September 24, 2015
Summary
Colorectal cancer (CRC) with BRAF V600E mutations shows resistance to targeted therapies. Understanding BRAF mutation biology in CRC is crucial for developing effective treatments.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) remains a significant cause of cancer mortality.
- Approximately 10% of CRC cases harbor the BRAF V600E mutation, a key oncogenic driver.
- BRAF inhibitors improve survival in some cancers but resistance is common.
Purpose of the Study:
- To review recent discoveries on BRAF mutation biology in colorectal cancer.
- To elucidate mechanisms of resistance to BRAF inhibitors in CRC.
- To compare BRAF inhibitor resistance pathways between CRC and melanoma.
Main Methods:
- Literature review of recent research on BRAF mutations in CRC.
- Analysis of studies investigating BRAF inhibitor efficacy and resistance.
- Comparative analysis of molecular mechanisms in different cancer types.
Main Results:
- BRAF V600E mutation is a critical factor in a subset of CRC.
- Colorectal cancer patients exhibit distinct resistance mechanisms to BRAF inhibitors compared to melanoma.
- Current combination therapies effective in melanoma show limited efficacy in CRC.
Conclusions:
- Understanding BRAF mutation biology in CRC is essential for therapeutic advancements.
- Novel therapeutic strategies are needed to overcome BRAF inhibitor resistance in CRC.
- Further research into CRC-specific resistance pathways will guide future treatment development.
More Related Videos
Related Concept Videos
02:38The Ras Gene
7.5K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.5K
01:20The Retinoblastoma Gene
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
01:20The Retinoblastoma Gene
2.8K
2.8K
02:07Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
01:20Mismatch Repair
7.0K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.0K
01:12Loss of Tumor Suppressor Gene Functions
6.3K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K